{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:45:13Z","timestamp":1782747913974,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtct.2026.03.027","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:54:44Z","timestamp":1774396484000},"page":"897.e1-897.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-9349","authenticated-orcid":false,"given":"Maria","family":"Huguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0295-2534","authenticated-orcid":false,"given":"Mireia","family":"Morgades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"Riquelme-Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f2nia","family":"Fuentes-Sanmartin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Josefa","family":"Jim\u00e9nez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4838-3171","authenticated-orcid":false,"given":"Merc\u00e8","family":"Ar\u00e9n-Jubany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1042-6024","authenticated-orcid":false,"given":"Josep-Maria","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Sancho-C\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Ferr\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jtct.2026.03.027_bib0001","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2021: the second year of the SARS-CoV-2 pandemic. A report from the EBMT activity survey","volume":"58","author":"Passweg","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.027_bib0002","series-title":"Thomas\u2019 Hematopoietic Cell Transplantation","first-page":"349","article-title":"The evaluation and counseling of candidates for hematopoietic cell transplantation","author":"Scott","year":"2016"},{"issue":"5","key":"10.1016\/j.jtct.2026.03.027_bib0003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.6004\/jnccn.2020.7559","article-title":"Eligibility criteria for patients undergoing allogeneic hematopoietic cell transplantation","volume":"18","author":"Kanate","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"8","key":"10.1016\/j.jtct.2026.03.027_bib0004","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/bmt.2010.94","article-title":"How we approach patient evaluation for hematopoietic stem cell transplantation","volume":"45","author":"Hamadani","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.03.027_bib0005","first-page":"e103","article-title":"Role of the multidisciplinary team in hematopoietic cell transplantation","volume":"25","author":"Kanate","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.027_bib0006","article-title":"Financial toxicity in allogeneic haematopoietic stem cell transplant patients from a social determinants of health perspective","volume":"70","author":"Huerga","year":"2024","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"10.1016\/j.jtct.2026.03.027_bib0007","first-page":"187","article-title":"The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients","volume":"4","author":"Meehan","year":"2006","journal-title":"J Support Oncol"},{"issue":"11","key":"10.1016\/j.jtct.2026.03.027_bib0008","doi-asserted-by":"crossref","first-page":"763.e1","DOI":"10.1016\/j.jtct.2023.07.013","article-title":"Racial and socioeconomic disparities in long-term outcomes among 1-year allogeneic HCT survivors","volume":"29","author":"Blue","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.jtct.2026.03.027_bib0009","first-page":"724","article-title":"Racial and ethnic disparities in hematopoietic cell transplantation outcomes: a CIBMTR study","volume":"126","author":"Baker","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.03.027_bib0010","first-page":"717","article-title":"The effect of limited-English proficiency on hematopoietic stem cell transplantation","volume":"26","author":"Robles","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.03.027_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2025.07.1015","article-title":"Language barriers and infectious post-transplant outcomes","author":"Wick","year":"2025","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.03.027_bib0012","first-page":"4301","article-title":"Caregiver support and outcomes in hematopoietic stem cell transplantation","volume":"30","author":"Pillay","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtct.2026.03.027_bib0013","first-page":"1","article-title":"The importance of caregiving in hematopoietic stem cell transplantation","volume":"33","author":"Molassiotis","year":"2018","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"10.1016\/j.jtct.2026.03.027_bib0014","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation\u2013specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.jtct.2026.03.027_bib0015","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1002\/cncr.24531","article-title":"Risk score for outcome after allogeneic hematopoietic stem cell transplantation","volume":"115","author":"Gratwohl","year":"2009","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.jtct.2026.03.027_bib0016","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1182\/bloodadvances.2024013074","article-title":"Racial, ethnic, and socioeconomic diversity and outcomes of patients with graft-versus-host disease: a CIBMTR analysis","volume":"8","author":"Farhadfar","year":"2024","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2026.03.027_bib0017","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41409-024-02327-x","article-title":"Disparities in access to hematopoietic cell transplant persist at a transplant center","volume":"59","author":"Shoag","year":"2024","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.03.027_bib0018","first-page":"605","article-title":"Barriers to the use of hematopoietic cell transplantation among economically disadvantaged populations","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2026.03.027_bib0019","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.2024027543","article-title":"Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"145","author":"Wuliji","year":"2025","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.03.027_bib0020","doi-asserted-by":"crossref","first-page":"353.e1","DOI":"10.1016\/j.jtct.2025.03.013","article-title":"Integrating social work throughout the hematopoietic cell transplantation trajectory to improve patient and caregiver outcomes","volume":"31","author":"Randall","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.jtct.2026.03.027_bib0021","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/cncr.32680","article-title":"Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"126","author":"El-Jawahri","year":"2020","journal-title":"Cancer"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726002356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:59:46Z","timestamp":1782745186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726002356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666636726002356"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.027","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}